4-Hydroxy-2,2,6,6-tetramethylpiperidine
2403-88-5CC1(C)CC(O)CC(C)(C)N1VDVUCLWJZJHFAV-UHFFFAOYSA-NRN given refers to parent cpd
2403-88-5DTXSID3029655CHEMBL117625安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 2.5% (5 of 201) of reports.
Danger
H302 (65.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P264+P265, P270, P272, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P333+P317, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 201 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
REACH registered substance: 2,2,6,6-tetramethylpiperidin-4-ol (EC: 219-291-2)
2,2,6,6-Tetramethyl-4-piperidinol: Does not have an individual approval but may be used under an appropriate group standard
Acute Tox. 4 (65.7%)
Acute toxicity (Oral) - Category 4
用途樹脂添加剤
用途スピンラベル合成試薬。
使用2,2,6,6-tetramethyl-4-piperidinol has been used to study the irradiation of Camptothecin (CPT) in aerated dimethylsulfoxide (DMSO) solution that leads to formation of singlet oxygen.
純化方法The piperidine crystallises from water as a hydrate and crystallises from dry ether or *C6H6 as the anhydrous base. The hydrochloride has m 282-284o (from EtOH/H2O), and the formate has m 207o(dec, from EtOH/EtOAc). [Mailey & Day J Org Chem 22 1061 1957, Beilstein 21 I 195, 21 III/IV 146, 21/1 V 159.]
化学的特性white to slightly beige crystalline powder